These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22662180)

  • 1. Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.
    Stautz D; Wewer UM; Kveiborg M
    PLoS One; 2012; 7(5):e37628. PubMed ID: 22662180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein.
    Dyczynska E; Syta E; Sun D; Zolkiewska A
    Int J Cancer; 2008 Jun; 122(11):2634-40. PubMed ID: 18241035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12.
    Qi Y; Duhachek-Muggy S; Li H; Zolkiewska A
    PLoS One; 2014; 9(3):e92536. PubMed ID: 24651654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-surface metalloprotease ADAM12 is internalized by a clathrin- and Grb2-dependent mechanism.
    Stautz D; Leyme A; Grandal MV; Albrechtsen R; van Deurs B; Wewer U; Kveiborg M
    Traffic; 2012 Nov; 13(11):1532-46. PubMed ID: 22882974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular roles of ADAM12 in health and disease.
    Kveiborg M; Albrechtsen R; Couchman JR; Wewer UM
    Int J Biochem Cell Biol; 2008; 40(9):1685-702. PubMed ID: 18342566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
    Fröhlich C; Klitgaard M; Noer JB; Kotzsch A; Nehammer C; Kronqvist P; Berthelsen J; Blobel C; Kveiborg M; Albrechtsen R; Wewer UM
    Biochem J; 2013 May; 452(1):97-109. PubMed ID: 23458101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM12 induces estrogen-independence in breast cancer cells.
    Roy R; Moses MA
    Breast Cancer Res Treat; 2012 Feb; 131(3):731-41. PubMed ID: 21387162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
    Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
    J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.
    Bourd-Boittin K; Le Pabic H; Bonnier D; L'Helgoualc'h A; Théret N
    J Biol Chem; 2008 Sep; 283(38):26000-9. PubMed ID: 18621736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM12 is a four-leafed clover: the excised prodomain remains bound to the mature enzyme.
    Wewer UM; Mörgelin M; Holck P; Jacobsen J; Lydolph MC; Johnsen AH; Kveiborg M; Albrechtsen R
    J Biol Chem; 2006 Apr; 281(14):9418-22. PubMed ID: 16455653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity.
    Albrechtsen R; Stautz D; Sanjay A; Kveiborg M; Wewer UM
    Exp Cell Res; 2011 Jan; 317(2):195-209. PubMed ID: 20951132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM12 localizes with c-Src to actin-rich structures at the cell periphery and regulates Src kinase activity.
    Stautz D; Sanjay A; Hansen MT; Albrechtsen R; Wewer UM; Kveiborg M
    Exp Cell Res; 2010 Jan; 316(1):55-67. PubMed ID: 19769962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM12: a potential target for the treatment of chronic wounds.
    Harsha A; Stojadinovic O; Brem H; Sehara-Fujisawa A; Wewer U; Loomis CA; Blobel CP; Tomic-Canic M
    J Mol Med (Berl); 2008 Aug; 86(8):961-9. PubMed ID: 18604515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.
    Narita D; Seclaman E; Ilina R; Cireap N; Ursoniu S; Anghel A
    Pathol Oncol Res; 2011 Jun; 17(2):375-85. PubMed ID: 21240579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular processing of metalloprotease disintegrin ADAM12.
    Cao Y; Kang Q; Zhao Z; Zolkiewska A
    J Biol Chem; 2002 Jul; 277(29):26403-11. PubMed ID: 12000744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
    Duhachek-Muggy S; Zolkiewska A
    BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
    Kveiborg M; Jacobsen J; Lee MH; Nagase H; Wewer UM; Murphy G
    Biochem J; 2010 Aug; 430(1):79-86. PubMed ID: 20533908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of ADAM12 gene in breast cancers.
    Nariţa D; Anghel A; Seclaman E; Ilina R; Cireap N; Ursoniu S
    Rom J Morphol Embryol; 2010; 51(4):669-76. PubMed ID: 21103624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM12-S stimulates bone growth in transgenic mice by modulating chondrocyte proliferation and maturation.
    Kveiborg M; Albrechtsen R; Rudkjaer L; Wen G; Damgaard-Pedersen K; Wewer UM
    J Bone Miner Res; 2006 Aug; 21(8):1288-96. PubMed ID: 16869727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.
    Rao VH; Kandel A; Lynch D; Pena Z; Marwaha N; Deng C; Watson P; Hansen LA
    Oncogene; 2012 Jun; 31(23):2888-98. PubMed ID: 21986939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.